Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 1/2016

01.02.2016 | Research Article

Treatment-related knowledge and skills of patients with haemophilia and their informal caregivers

verfasst von: Teddy Novais, Antoine Duclos, Remi Varin, Isabelle Lopez, Valérie Chamouard

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background Replacement therapy in haemophilia plays an important role in the effective management of this rare bleeding disorder and requires a high level of knowledge and practical skills. Objective To evaluate and to compare the knowledge and skills about the medicines and their management among people with haemophilia treated with clotting factor concentrates, and their informal caregivers. Setting Eight Hospital Pharmacies working closely with Haemophilia Care Centres in France. Method In this cross-sectional and multi-centre study, 26-item questionnaire was specifically developed to assess the knowledge and skills. Face-to-face interviews using a questionnaire were conducted with patients and caregivers. Main outcome measure Level of knowledge and skills about disease, treatment and medication management. Results This study included 80 patients and 55 caregivers. Although most interviewees had basic knowledge of the treatment, only 43.7 % knew the effect of clotting factor concentrates on the haemostasis process. Similarly, only 12.7 % of the patients and 30.9 % of the caregivers referred to inhibitors as adverse effects. Despite intensive training for home treatment, 55.7 % reported difficulties with reconstitution or injection. The knowledge required for the responsible management of their medications had not been totally acquired: only 17 participants were indeed familiar with the medication storage conditions; 29 patients and 9 caregivers had already experienced an emergency which they had to treat with no medicine available at home; and 47.4 % of participants had already thrown away an unused drug vial. Conclusion This study shows the need of a regular update and to renew awareness of haemophilia treatment specificities among these populations. The identified needs suggest that we should more invest in educational techniques or therapeutic education programs more focused on medication management.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat O’Mahony B, Black C. Expanding hemophilia care in developing countries. Semin Thromb Hemost. 2005;31(5):561–8.CrossRefPubMed O’Mahony B, Black C. Expanding hemophilia care in developing countries. Semin Thromb Hemost. 2005;31(5):561–8.CrossRefPubMed
2.
Zurück zum Zitat Iorio A, Halimeh S, Holzhauer S, Goldenberg N, Marchesini E, Marcucci M, et al. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review. J Thromb Haemost. 2010;8(6):1256–65.CrossRefPubMed Iorio A, Halimeh S, Holzhauer S, Goldenberg N, Marchesini E, Marcucci M, et al. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review. J Thromb Haemost. 2010;8(6):1256–65.CrossRefPubMed
3.
Zurück zum Zitat Makris M, Calizzani G, Fischer K, Gilman EA, Hay CRM, Lassila R, et al. EUHASS: the European haemophilia safety surveillance system. Thromb Res. 2011;127(Suppl 2):S22–5.CrossRefPubMed Makris M, Calizzani G, Fischer K, Gilman EA, Hay CRM, Lassila R, et al. EUHASS: the European haemophilia safety surveillance system. Thromb Res. 2011;127(Suppl 2):S22–5.CrossRefPubMed
4.
Zurück zum Zitat Plug I, van der Bom JG, Peters M, Mauser-Bunschoten EP, de Goede-Bolder A, Heijnen L, et al. Thirty years of hemophilia treatment in the Netherlands, 1972–2001. Blood. 2004;104(12):3494–500.CrossRefPubMed Plug I, van der Bom JG, Peters M, Mauser-Bunschoten EP, de Goede-Bolder A, Heijnen L, et al. Thirty years of hemophilia treatment in the Netherlands, 1972–2001. Blood. 2004;104(12):3494–500.CrossRefPubMed
5.
Zurück zum Zitat Rabiner SF, Telfer MC. Home transfusion for patients with hemophilia A. N Engl J Med. 1970;283(19):1011–5.CrossRefPubMed Rabiner SF, Telfer MC. Home transfusion for patients with hemophilia A. N Engl J Med. 1970;283(19):1011–5.CrossRefPubMed
6.
Zurück zum Zitat Schrijvers LH, Beijlevelt-van der Zande M, Peters M, Schuurmans MJ, Fischer K. Learning intravenous infusion in haemophilia: experience from the Netherlands. Haemophilia. 2012;18(4):516–20.CrossRefPubMed Schrijvers LH, Beijlevelt-van der Zande M, Peters M, Schuurmans MJ, Fischer K. Learning intravenous infusion in haemophilia: experience from the Netherlands. Haemophilia. 2012;18(4):516–20.CrossRefPubMed
7.
Zurück zum Zitat Schrijvers LH, Uitslager N, Schuurmans MJ, Fischer K. Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review. Haemophilia. 2013;19(3):355–61.CrossRefPubMed Schrijvers LH, Uitslager N, Schuurmans MJ, Fischer K. Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review. Haemophilia. 2013;19(3):355–61.CrossRefPubMed
8.
Zurück zum Zitat Lindvall K, Colstrup L, Wollter I-M, Klemenz G, Loogna K, Grönhaug S, et al. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia. Haemophilia. 2006;12(1):47–51.CrossRefPubMed Lindvall K, Colstrup L, Wollter I-M, Klemenz G, Loogna K, Grönhaug S, et al. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia. Haemophilia. 2006;12(1):47–51.CrossRefPubMed
9.
Zurück zum Zitat De Moerloose P, Urbancik W, Van Den Berg HM, Richards M. A survey of adherence to haemophilia therapy in six European countries: results and recommendations. Haemophilia. 2008;14(5):931–8.CrossRefPubMed De Moerloose P, Urbancik W, Van Den Berg HM, Richards M. A survey of adherence to haemophilia therapy in six European countries: results and recommendations. Haemophilia. 2008;14(5):931–8.CrossRefPubMed
10.
Zurück zum Zitat Nilson J, Schachter C, Mulder K, Hahn M, Steele M, Hilliard P, et al. A qualitative study identifying the knowledge, attitudes and behaviours of young men with mild haemophilia. Haemophilia. 2012;18(3):e120–5.CrossRefPubMed Nilson J, Schachter C, Mulder K, Hahn M, Steele M, Hilliard P, et al. A qualitative study identifying the knowledge, attitudes and behaviours of young men with mild haemophilia. Haemophilia. 2012;18(3):e120–5.CrossRefPubMed
11.
Zurück zum Zitat Simmons GM, Frick N, Wang A, Miller ME, Fragueiro D. Identifying information needs among children and teens living with haemophilia. Haemophilia. 2014;20(1):1–8.CrossRefPubMed Simmons GM, Frick N, Wang A, Miller ME, Fragueiro D. Identifying information needs among children and teens living with haemophilia. Haemophilia. 2014;20(1):1–8.CrossRefPubMed
12.
Zurück zum Zitat Khair K, Meerabeau L, Gibson F. Self-management and skills acquisition in boys with haemophilia. Health Expect. 2015;18(5):1105–13.CrossRefPubMed Khair K, Meerabeau L, Gibson F. Self-management and skills acquisition in boys with haemophilia. Health Expect. 2015;18(5):1105–13.CrossRefPubMed
13.
Zurück zum Zitat Magli-Barioz D, Ounnoughène N, Paugy P, Quarrè M-C, Vassilief D, Lopez I, et al. Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications. Haemophilia. 2004;10(5):572–81.CrossRefPubMed Magli-Barioz D, Ounnoughène N, Paugy P, Quarrè M-C, Vassilief D, Lopez I, et al. Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications. Haemophilia. 2004;10(5):572–81.CrossRefPubMed
14.
Zurück zum Zitat El Dakhakhny AM, Hesham MA, Hassan TH, El Awady S, Hanfy MM. Impact of health instructions on improving knowledge and practices of haemophilia A adolescents: a single centre experience. Haemophilia. 2014;20(4):e260–6.CrossRefPubMed El Dakhakhny AM, Hesham MA, Hassan TH, El Awady S, Hanfy MM. Impact of health instructions on improving knowledge and practices of haemophilia A adolescents: a single centre experience. Haemophilia. 2014;20(4):e260–6.CrossRefPubMed
15.
Zurück zum Zitat Mulders G, de Wee EM, Vahedi Nikbakht-Van de Sande MCVM, Kruip MJHA, Elfrink EJ, Leebeek FWG. E-learning improves knowledge and practical skills in haemophilia patients on home treatment: a randomized controlled trial. Haemophilia. 2012;18(5):693–8.CrossRefPubMed Mulders G, de Wee EM, Vahedi Nikbakht-Van de Sande MCVM, Kruip MJHA, Elfrink EJ, Leebeek FWG. E-learning improves knowledge and practical skills in haemophilia patients on home treatment: a randomized controlled trial. Haemophilia. 2012;18(5):693–8.CrossRefPubMed
16.
Zurück zum Zitat Lindvall K, Colstrup L, Loogna K, Wollter I, Grönhaug S. Knowledge of disease and adherence in adult patients with haemophilia. Haemophilia. 2010;16(4):592–6.PubMed Lindvall K, Colstrup L, Loogna K, Wollter I, Grönhaug S. Knowledge of disease and adherence in adult patients with haemophilia. Haemophilia. 2010;16(4):592–6.PubMed
17.
Zurück zum Zitat Duncan N, Roberson C, Lail A, Donfield S, Shapiro A. A haemophilia disease management programme targeting cost and utilization of specialty pharmaceuticals. Haemophilia. 2014;20(4):519–26.CrossRefPubMed Duncan N, Roberson C, Lail A, Donfield S, Shapiro A. A haemophilia disease management programme targeting cost and utilization of specialty pharmaceuticals. Haemophilia. 2014;20(4):519–26.CrossRefPubMed
18.
Zurück zum Zitat Furmedge J, Lima S, Monagle P, Barnes C, Newall F. “I don’t want to hurt him”. Parents’ experiences of learning to administer clotting factor to their child. Haemophilia. 2013;19(2):206–11.CrossRefPubMed Furmedge J, Lima S, Monagle P, Barnes C, Newall F. “I don’t want to hurt him”. Parents’ experiences of learning to administer clotting factor to their child. Haemophilia. 2013;19(2):206–11.CrossRefPubMed
Metadaten
Titel
Treatment-related knowledge and skills of patients with haemophilia and their informal caregivers
verfasst von
Teddy Novais
Antoine Duclos
Remi Varin
Isabelle Lopez
Valérie Chamouard
Publikationsdatum
01.02.2016
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 1/2016
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0207-z

Weitere Artikel der Ausgabe 1/2016

International Journal of Clinical Pharmacy 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.